Key Insights

Highlights

Success Rate

95% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

1.8%

1 terminated out of 56 trials

Success Rate

94.7%

+8.2% vs benchmark

Late-Stage Pipeline

9%

5 trials in Phase 3/4

Results Transparency

6%

1 of 18 completed with results

Key Signals

1 with results95% success

Data Visualizations

Phase Distribution

41Total
Not Applicable (24)
Early P 1 (1)
P 1 (1)
P 2 (10)
P 3 (5)

Trial Status

Completed18
Recruiting17
Unknown7
Not Yet Recruiting6
Active Not Recruiting6
Suspended1

Trial Success Rate

94.7%

Benchmark: 86.5%

Based on 18 completed trials

Clinical Trials (56)

Showing 20 of 20 trials
NCT07682714Not ApplicableRecruiting

Capturing Food Intake in Patients Undergoing Radiation Therapy for Cancer

NCT07324577Not ApplicableRecruitingPrimary

Effectiveness of Virtual Reality (VR) in the Management of Anxiety for Patients Undergoing Radiotherapy

NCT06159335Phase 3Recruiting

18F-FLUC PET/MR in Patients With Brain Mets

NCT07652060Not ApplicableNot Yet RecruitingPrimary

EVALUATION OF THE BENEFITS OF SOPHROLOGY FOR PATIENTS UNDERGOING RADIOTHERAPY

NCT05335148Phase 1Active Not RecruitingPrimary

Study to Evaluate the Safety of Colchicine

NCT07598851Not ApplicableCompleted

Virtual Reality Education for Radiation Therapy Patients

NCT05743569Active Not Recruiting

3D Specimen Maps for RT Planning

NCT07540260Not ApplicableRecruitingPrimary

CAIX PET/ CT Guided Radiation Therapy in CcRCC.

NCT03042156Completed

Immunotherapy And Palliative Radiotherapy Combined In Patients With Advanced Malignancy

NCT02422550RecruitingPrimary

Imaging Acquisition and Analysis Methods for Optimization of MRI Radiation Oncology Simulation and Response Assessment

NCT06746428Not ApplicableRecruitingPrimary

Activity Coaching During Pelvic Radiation Therapy

NCT04983095Not ApplicableRecruiting

Metastasis Directed Stereotactic Body Radiotherapy for Oligo Metastatic Hormone Sensitive Prostate Cancer

NCT07415681Phase 2Not Yet Recruiting

GCCC 2578 Randomized Photon vs Proton RT for Newly Diagnosed Gynecologic Primaries

NCT06546592Not ApplicableRecruiting

Locally Optimised Contouring With AI Technology for Radiotherapy

NCT06583070RecruitingPrimary

SABR Combined With Targeted Therapy and Anti-PD-1 for Recurrent or Metastatic Renal Cancer

NCT06579248Early Phase 1Recruiting

Intraoral Hypothermia Device for Preserving Taste During Radiation

NCT05351294Phase 3SuspendedPrimary

Assessment of Early Radiation Oncology Involvement Alongside Standard Oncologic Care in the Managemet

NCT07279077Phase 2Recruiting

Node-Sparing Low-Dose Radiotherapy Concurrent With Chemotherapy and PD-1 Inhibitor in pMMR/MSS High-Risk Locally Advanced Colon Cancer: A Prospective, Single-Arm, Phase II Trial

NCT05721053Active Not Recruiting

Improving Outcomes for Older Adults Undergoing Radiation Therapy

NCT06128863Phase 2Active Not Recruiting

Pembrolizumab in Combination With Eftilagimod Alpha and Radiotherapy in Neoadjuvant Treatment of Patients With Soft Tissue Sarcoma - EFTISARC-NEO Trial

Scroll to load more

Research Network

Activity Timeline